{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:41:23Z","timestamp":1770885683885,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.amepre.2019.04.024","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:38:32Z","timestamp":1564619912000},"page":"330-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada"],"prefix":"10.1016","volume":"57","author":[{"given":"Mary Clare","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiru","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-J S.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2019.04.024_bib0001","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug consumption rooms: an overview of provision and evidence. www.emcdda.europa.eu\/topics\/pods\/drug-consumption-rooms. Published 2018. Accessed January 8, 2018."},{"issue":"5","key":"10.1016\/j.amepre.2019.04.024_bib0002","doi-asserted-by":"crossref","first-page":"161\u2012183","DOI":"10.1007\/s11904-017-0363-y","article-title":"Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review","volume":"14","author":"Kennedy","year":"2017","journal-title":"Curr HIV AIDS Rep"},{"key":"10.1016\/j.amepre.2019.04.024_bib0003","unstructured":"Health Canada. Supervised consumption sites: status of applications. www.canada.ca\/en\/health-canada\/services\/substance-abuse\/supervised-consumption-sites\/status-application.html. Published 2018. Accessed September 1, 2018."},{"issue":"28","key":"10.1016\/j.amepre.2019.04.024_bib0004","article-title":"Supervised injection facilities in Canada: past, present, and future","volume":"14","author":"Kerr","year":"2017","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.amepre.2019.04.024_bib0005","doi-asserted-by":"crossref","first-page":"126\u2012130","DOI":"10.1016\/j.amepre.2005.04.011","article-title":"Do supervised injecting facilities attract higher-risk injection drug users?","volume":"29","author":"Wood","year":"2005","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.amepre.2019.04.024_bib0006","doi-asserted-by":"crossref","first-page":"770\u2012773","DOI":"10.2105\/AJPH.2004.057828","article-title":"Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility","volume":"96","author":"Wood","year":"2006","journal-title":"Am J Public Health"},{"issue":"9775","key":"10.1016\/j.amepre.2019.04.024_bib0007","doi-asserted-by":"crossref","first-page":"1429\u20121437","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.amepre.2019.04.024_bib0008","doi-asserted-by":"crossref","first-page":"731\u2012734","DOI":"10.1503\/cmaj.1040774","article-title":"Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users","volume":"171","author":"Wood","year":"2004","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.amepre.2019.04.024_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1747-597X-1-13","article-title":"Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime","volume":"1","author":"Wood","year":"2006","journal-title":"Subst Abus Treat Prev Policy"},{"issue":"9482","key":"10.1016\/j.amepre.2019.04.024_bib0010","doi-asserted-by":"crossref","first-page":"316\u2012318","DOI":"10.1016\/S0140-6736(05)66475-6","article-title":"Safer injection facility use and syringe sharing in injection drug users","volume":"366","author":"Kerr","year":"2005","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.amepre.2019.04.024_bib0011","first-page":"172\u2012176","article-title":"Injection drug use cessation and use of North America's first medically supervised safer injecting facility","volume":"113","author":"DeBeck","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2019.04.024_bib0012","doi-asserted-by":"crossref","first-page":"1\u20126","DOI":"10.1016\/j.jsat.2017.08.003","article-title":"Use of on-site detoxification services co-located with a supervised injection facility","volume":"82","author":"Gaddis","year":"2017","journal-title":"J Subst Abus Treat"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0013","doi-asserted-by":"crossref","first-page":"916\u2012919","DOI":"10.1111\/j.1360-0443.2007.01818.x","article-title":"Rate of detoxification service use and its impact among a cohort of supervised injecting facility users","volume":"102","author":"Wood","year":"2007","journal-title":"Addiction"},{"issue":"23","key":"10.1016\/j.amepre.2019.04.024_bib0014","doi-asserted-by":"crossref","first-page":"2512\u20122514","DOI":"10.1056\/NEJMc052939","article-title":"Attendance at supervised injecting facilities and use of detoxification services","volume":"354","author":"Wood","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2019.04.024_bib0015","doi-asserted-by":"crossref","first-page":"151\u2012158","DOI":"10.1016\/j.socscimed.2014.01.051","article-title":"\u2018Safer environment interventions\u2019: a qualitative synthesis of the experiences and perceptions of people who inject drugs","volume":"106","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.amepre.2019.04.024_bib0016","doi-asserted-by":"crossref","first-page":"48\u201268","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.amepre.2019.04.024_bib0017","doi-asserted-by":"crossref","first-page":"42\u201243","DOI":"10.2105\/AJPH.2016.303523","article-title":"Overdose prevention in the United States: a call for supervised injection sites","volume":"107","author":"Kennedy","year":"2017","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2019.04.024_bib0018","doi-asserted-by":"crossref","first-page":"73\u201277","DOI":"10.1016\/j.ypmed.2018.02.026","article-title":"Public support for safe consumption sites and syringe services programs to combat the opioid epidemic","volume":"111","author":"McGinty","year":"2018","journal-title":"Prev Med"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0019","doi-asserted-by":"crossref","first-page":"628\u2012630","DOI":"10.1016\/j.drugpo.2013.05.008","article-title":"Supervised consumption rooms: the French paradox","volume":"24","author":"Jauffret-Roustide","year":"2013","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2019.04.024_bib0020","unstructured":"Highleyman LUS. Cities consider supervised injection sites. Medpage Today. www.medpagetoday.com\/reading-room\/aga\/lower-gi\/73190. Published May 31, 2018. Accessed November 18, 2018."},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0021","doi-asserted-by":"crossref","first-page":"919\u2012922","DOI":"10.1016\/j.amepre.2017.06.010","article-title":"Addressing the nation's opioid epidemic: lessons from an unsanctioned supervised injection site in the U.S","volume":"53","author":"Kral","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2019.04.024_bib0022","unstructured":"National Institute on Drug Abuse. Overdose death rates.www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates. Published August 9, 2018. Accessed August 30, 2018."},{"key":"10.1016\/j.amepre.2019.04.024_bib0023","unstructured":"Health Canada. Overview of national data on opioid-related harms and deaths. www.canada.ca\/en\/health-canada\/services\/substance-use\/problematic-prescription-drug-use\/opioids\/data-surveillance-research\/harms-deaths.html. Published 2018. Accessed September 1, 2018."},{"key":"10.1016\/j.amepre.2019.04.024_bib0024","unstructured":"Rosenstein RJ. Fight drug abuse, don't subsidize it. The New York Times. www.nytimes.com\/2018\/08\/27\/opinion\/opioids-heroin-injection-sites.html. Published August 27, 2018. Accessed November 16, 2018."},{"key":"10.1016\/j.amepre.2019.04.024_bib0025","unstructured":"Highleyman L. Supervised injection sites reduce drug-related harm. Medpage Today. www.medpagetoday.com\/hivaids\/hivaids\/75871. Published October 23, 2018. Accessed November 18, 2018."},{"key":"10.1016\/j.amepre.2019.04.024_bib0026","unstructured":"The Canadian Press. Ontario to review safe injection, overdose prevention sites, health minister says. CBC News. www.cbc.ca\/news\/canada\/toronto\/ontario-safe-injection-sites-limbo-1.4760002. Published July 24, 2018. Accessed November 18, 2018."},{"issue":"3","key":"10.1016\/j.amepre.2019.04.024_bib0027","doi-asserted-by":"crossref","first-page":"639\u2012648","DOI":"10.1177\/002204260303300306","article-title":"The Sydney Medically Supervised Injecting Centre: client characteristics and predictors of frequent attendance during the first 12 months of operation","volume":"33","author":"Kimber","year":"2003","journal-title":"J Drug Issues"},{"issue":"4","key":"10.1016\/j.amepre.2019.04.024_bib0028","doi-asserted-by":"crossref","first-page":"391\u2012406","DOI":"10.1080\/09581590400027528","article-title":"The Sydney Medically Supervised Injecting Centre: reducing harm associated with heroin overdose","volume":"14","author":"van Beek","year":"2004","journal-title":"Crit Public Health"},{"issue":"3","key":"10.1016\/j.amepre.2019.04.024_bib0029","doi-asserted-by":"crossref","first-page":"663\u2012688","DOI":"10.1177\/002204260303300308","article-title":"Drug consumption rooms in Hamburg, Germany: evaluation of the effects on harm reduction and the reduction of public nuisance","volume":"33","author":"Zurhold","year":"2003","journal-title":"J Drug Issues"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0030","doi-asserted-by":"crossref","first-page":"547\u2012549","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users","volume":"280","author":"Strathdee","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amepre.2019.04.024_bib0031","first-page":"405\u2012410","article-title":"Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?","volume":"165","author":"Wood","year":"2001","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1016\/j.amepre.2019.04.024_bib0032","first-page":"160\u2012166","article-title":"Factors associated with frequent needle exchange program in injection drug users in Vancouver, Canada","volume":"17","author":"Archibald","year":"1998","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0033","doi-asserted-by":"crossref","first-page":"1020\u20121030","DOI":"10.1007\/s11524-011-9600-7","article-title":"Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny county, Pennsylvania","volume":"88","author":"Bennett","year":"2011","journal-title":"J Urban Health"},{"issue":"5","key":"10.1016\/j.amepre.2019.04.024_bib0034","doi-asserted-by":"crossref","first-page":"1088\u20121093","DOI":"10.1016\/j.addbeh.2006.07.013","article-title":"Injection drug users\u2019 perceptions regarding use of a medically supervised safer injecting facility","volume":"32","author":"Petrar","year":"2007","journal-title":"Addict Behav"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0035","doi-asserted-by":"crossref","first-page":"743\u2012756","DOI":"10.1177\/1049732311400919","article-title":"Injection drug users\u2019 access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture","volume":"21","author":"Small","year":"2011","journal-title":"Qual Health Res"},{"key":"10.1016\/j.amepre.2019.04.024_bib0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-016-0115-0","article-title":"A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms","volume":"13","author":"Toth","year":"2016","journal-title":"Harm Reduct J"},{"issue":"17","key":"10.1016\/j.amepre.2019.04.024_bib0037","doi-asserted-by":"crossref","first-page":"2371\u20122380","DOI":"10.1097\/QAD.0b013e328315cdd3","article-title":"Differential impact of adherence on long-term treatment response among naive HIV-infected individuals","volume":"22","author":"Lima","year":"2008","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0038","doi-asserted-by":"crossref","first-page":"602\u2012612","DOI":"10.1080\/09595230801995668","article-title":"Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre","volume":"27","author":"Kimber","year":"2008","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"10.1016\/j.amepre.2019.04.024_bib0039","doi-asserted-by":"crossref","first-page":"412\u2012422","DOI":"10.1521\/aeap.2011.23.5.412","article-title":"Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users","volume":"23","author":"Reddon","year":"2011","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.amepre.2019.04.024_bib0040","doi-asserted-by":"crossref","first-page":"76\u201283","DOI":"10.1016\/j.drugalcdep.2015.03.005","article-title":"Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort","volume":"151","author":"Xia","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.amepre.2019.04.024_bib0041","doi-asserted-by":"crossref","first-page":"695\u2012704","DOI":"10.1093\/aje\/kwg209","article-title":"Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988\u20132000: description and determinants","volume":"158","author":"Galai","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.amepre.2019.04.024_bib0042","doi-asserted-by":"crossref","first-page":"829\u2012836","DOI":"10.1093\/aje\/kwq441","article-title":"Trajectories of injection drug use over 20 years (1988\u20132008) in Baltimore, Maryland","volume":"173","author":"Genberg","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amepre.2019.04.024_bib0043","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7517-1-9","article-title":"Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users","volume":"1","author":"Wood","year":"2004","journal-title":"Harm Reduct J"},{"issue":"8","key":"10.1016\/j.amepre.2019.04.024_bib0044","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.amepre.2019.04.024_bib0045","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amepre.2019.04.024_bib0046","doi-asserted-by":"crossref","first-page":"e5945","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.amepre.2019.04.024_bib0047","doi-asserted-by":"crossref","first-page":"1974\u20121981","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amepre.2019.04.024_bib0048","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amepre.2019.04.024_bib0049","doi-asserted-by":"crossref","first-page":"81\u201286","DOI":"10.1136\/jech.2007.069013","article-title":"Public injecting among a cohort of injecting drug users in Vancouver, Canada","volume":"63","author":"DeBeck","year":"2009","journal-title":"J Epidemiol Commun Health"},{"issue":"10","key":"10.1016\/j.amepre.2019.04.024_bib0050","doi-asserted-by":"crossref","first-page":"1384\u20121393","DOI":"10.1111\/j.1360-0443.2006.01556.x","article-title":"Public injecting and the need for \u2018safer environment interventions\u2019 in the reduction of drug-related harm","volume":"101","author":"Rhodes","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.amepre.2019.04.024_bib0051","doi-asserted-by":"crossref","first-page":"27\u201236","DOI":"10.1016\/j.drugpo.2006.11.019","article-title":"Public injection settings in Vancouver: physical environment, social context and risk","volume":"18","author":"Small","year":"2007","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.amepre.2019.04.024_bib0052","doi-asserted-by":"crossref","first-page":"157\u2012165","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison \u2014 a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2019.04.024_bib0053","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2458-9-156","article-title":"Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis","volume":"9","author":"Milloy","year":"2009","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.amepre.2019.04.024_bib0054","doi-asserted-by":"crossref","first-page":"3681\u20123707","DOI":"10.1177\/0306624X17747829","article-title":"Narratives of young men with injecting drug use histories leaving adult prison","volume":"62","author":"Walker","year":"2018","journal-title":"Int J Offender Ther Comp Criminol"},{"issue":"6","key":"10.1016\/j.amepre.2019.04.024_bib0055","doi-asserted-by":"crossref","first-page":"693\u2012699","DOI":"10.1080\/09595230801956157","article-title":"Incarceration experiences in a cohort of active injection drug users","volume":"27","author":"Milloy","year":"2008","journal-title":"Drug Alcohol Rev"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719302181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719302181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:53:23Z","timestamp":1760082803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379719302181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0749379719302181"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2019.04.024","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2019.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}